Navigation Links
Still River Systems, Inc. Secures $33 Million in Private Financing
Date:3/17/2009

LITTLETON, Mass., March 17 /PRNewswire/ -- Still River Systems, Inc., a provider of proton therapy solutions, announced today the closing of a private financing round of $33 million co-led by Venrock Associates and existing investor Caxton Health and Life Sciences, with participation by CHL Medical Partners.

Proceeds from this financing will accelerate the development of the company's Monarch250 Proton Therapy System. Still River Systems is committed to advancing the field of radiation treatment by providing an affordable and accessible proton therapy option for cancer patients. Still River Systems' current customers and industry partners include the Siteman Cancer Center at Barnes Jewish Hospital and Washington University School of Medicine in St. Louis, MO, one of 21 members of the prestigious National Comprehensive Cancer Network and scheduled to install Still River System's first proton therapy system this year. With unprecedented demand for proton therapy in recent years, other pending delivery sites include several of the most technologically advanced and influential providers in the radiation therapy community.

"Completion of this financing illustrates the investment community's confidence in Still River's business model and our ability to execute on our plan," said Marc Buntaine, Chief Executive Officer of Still River Systems. "Given today's economic environment, this strong financial support is a true endorsement of our growing leadership in the radiation therapy marketplace. We are pleased with the continued participation of our existing investors and warmly welcome our new investor partners, Venrock Associates and CHL Medical Partners." In conjunction with this financing, Dr. Anders Hove of Venrock Associates and Dr. Myles Greenberg of CHL Medical Partners will join Still River Systems' Board of Directors.

About Venrock Associates

Venrock is a premier venture capital firm with offices in Palo Alto, New York, Cambridge, MA, and Israel. Originally established as the venture capital arm of the Rockefeller family, Venrock continues a seven-decade tradition of partnering with entrepreneurs to establish successful, enduring companies. For more information, please visit Venrock's website at www.venrock.com.

About CHL Medical Partners

CHL Medical Partners is a premier venture capital firm dedicated to partnering with entrepreneurs and inventors to create and finance innovative biotechnology, molecular diagnostic, healthcare service and medical device companies. For more information, visit www.chlmedical.com.

About Still River Systems

Still River Systems, based in Littleton, Massachusetts, is dedicated to providing physicians, and their patients, access to high quality, cost-effective proton therapy solutions. Still River Systems is developing the Monarch250, an affordable, precise and compact proton therapy system for cancer treatment. The Monarch250 has not been cleared by the US Food and Drug Administration for clinical use. For more information on Still River Systems and the Monarch250 Proton Therapy System, please call 978-540-1500 or visit www.StillRiverSystems.com.


'/>"/>
SOURCE Still River Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Pharmos Corporation Announces Modification to Dextofisopam Trial Size, Objectives Can Still Be Achieved
2. PreMD Reduces Staffing, Operations - FDA Appeal Still in Process
3. New survey: Flu Shot Still not Catching on, Especially at Retail Clinics
4. New study finds blacks still lag in obtaining total knee replacements for arthritis
5. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
6. Cancer death rates dropping among African Americans but survival rates still low
7. Metoprolol Succinate Recalled: Brand Name Drug Scarce But Still Available at Low Cost from Other Countries, PharmacyChecker.com Announces
8. Salmonella Infection Numbers Still Rising; Recalls Rise Also
9. Salmonella Infection Numbers Still Rising
10. Photos: Despite Widespread Awareness, Most Women Still Dont Feel at Risk for Cervical Cancer
11. Officials Still Seek Source of Salmonella Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... May 04, 2016 , ... May kicked off with Melanoma Monday ... States. Dermatologist Dr. Ellen Turner is encouraging her patients, as well as residents all ... skin safety and health now and in the future. , The dermatology-specific awareness month ...
(Date:5/4/2016)... ... May 04, 2016 , ... Nordic ... supports cellular and metabolic health. This synergistic combination of omega-3 fatty acids and ... with 150 mg of reduced glutathione and 200 mg of N-Acetylcysteine (NAC). ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... today announced that it was chosen as the Pharmaceutical News Provider of the ... The awards acknowledge the hard work and dedication of community members who strive ...
(Date:5/4/2016)... ... May 04, 2016 , ... AudioEducator is the country's top ... months, AudioEducator has lined up some informative training session for the medical coding ... compliance know-how and practical, easy-to-apply advice. , On Thursday, May 19, AudioEducator will ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... a powerful cellular therapy software application that helps blood and marrow transplant (BMT) ... Since Transtem’s initial launch, Mediware has continued to enhance core application features. These ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... 2016  Specialty Silicone Fabricators is offering teachers ... a cleanroom works. The free visual aid provides ... technology. Chris Mazelin , ... SSF enthusiastically supports the Science, Technology, Engineering and ... next generation of innovators. We want to provide ...
(Date:5/3/2016)... PROVO, Utah , May 3, 2016  Forté Elements, LLC (Forté) is excited ... use nutritional products that address the nutritional needs of recovery for a variety of ... its products. Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/3/2016)... , May 3, 2016 ... heute bekannt, dass sie einen entscheidenden Meilenstein ... haben: Ein Aufruf zum Handeln, um Patientenresultate ... Veröffentlichung trägt zu Fortschritten im Verständnis der ... hervor, ein Bewusstsein für Hepatische Enzephalopathie in ...
Breaking Medicine Technology: